[1]US Department of Health and Human Services. Agency for Healthcare Research and Quality. Management of allergic and nonallergic rhinitis. May 2002. AHQR publication 02:E023, Boston, MA. Summary, Evidence Report/Technology Assessment: No 54. http://www.ahrq.gov/clinic/epcsums/rhinsum.htm (Accessed on August 03, 2007).
[2]Settipane RA. Demographics and epidemiology of allergic and nonallergic rhinitis. Allergy Asthma Proc 2001; 22:185.
[3]Singh K, Axelrod S, Bielory L. The epidemiology of ocular and nasal allergy in the United States, 1988-1994. J Allergy Clin Immunol 2010; 126:778.
[4]Wu WF, Wan KS, Wang SJ, et al. Prevalence, severity, and time trends of allergic conditions in 6-to-7-year-old schoolchildren in Taipei. J Investig Allergol Clin Immunol 2011; 21:556.
[5]Meltzer EO, Blaiss MS, Derebery MJ, et al. Burden of allergic rhinitis: results from the Pediatric Allergies in America survey. J Allergy Clin Immunol 2009; 124:S43.
[6]Abdulrahman H, Hadi U, Tarraf H, et al. Nasal allergies in the Middle Eastern population: results from the "Allergies in Middle East Survey". Am J Rhinol Allergy 2012; 26 Suppl 1:S3.
[7]Kulig M, Klettke U, Wahn V, et al. Development of seasonal allergic rhinitis during the first 7 years of life. J Allergy Clin Immunol 2000; 106:832.
[8]Westman M, Stjärne P, Asarnoj A, et al. Natural course and comorbidities of allergic and nonallergic rhinitis in children. J Allergy Clin Immunol 2012; 129:403.
Dykewicz MS, Wallace DV, Baroody F, et al. Treatment of seasonal allergic rhinitis: An evidence-based focused 2017 guideline update. Ann Allergy Asthma Immunol 2017; 119:489.
[9]Wallace DV, Dykewicz MS, Oppenheimer J, et al. Pharmacologic Treatment of Seasonal Allergic Rhinitis: Synopsis of Guidance From the 2017 Joint Task Force on Practice Parameters. Ann Intern Med 2017; 167:876.
[10]Cutler DL, Banfield C, Affrime MB. Safety of Mometasone Furoate Nasal Spray in Children with Allergic Rhinitis as Young as 2 Years of Age: A Randomized Controlled Trial. Pediatr Asthma Allergy Immunol 2006; 19:146.
[11]The US FDA issued a consumer warning regarding the risk of N. fowleri infection. http://www.fda.gov/ForConsumers/ConsumerUpdates/ucm316375.htm (Accessed on September 04, 2012).
[12]Information about Naegleria infection is available online from the United States Centers for disease control. http://www.cdc.gov/parasites/naegleria/faqs.html#how_infect.
[13]Zhang X, Lan F, Zhang Y, Zhang L. Chinese Herbal Medicine to Treat Allergic Rhinitis: Evidence From a Meta-Analysis. Allergy Asthma Immunol Res 2018; 10:34.
[14]Saxena VS, Venkateshwarlu K, Nadig P, et al. Multicenter clinical trials on a novel polyherbal formulation in allergic rhinitis. Int J Clin Pharmacol Res 2004; 24:79.